Kaavya Paruchuri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kaavya Paruchuri has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Rosenzweig
Stanley and Judith Frankel Institute for Heart and Brain Health, University of Michigan Medical Center, Ann Arbor, MI, USA
1 shared publication - Bruce M. Spiegelman
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA
1 shared publication - Carolin Lerchenmüller
Chair for Gender Medicine, University of Zurich, Zurich, Switzerland
1 shared publication - Chunyang Xiao
Cardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
1 shared publication - Colin Platt
Cardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
1 shared publication - Nina Mann
Division of Nephrology, Boston Children's Hospital, Boston, MA, United States
1 shared publication
Latest Publications
- Open Access
- 16 June 2016
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 1 (9)
CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury
The mechanisms by which exercise mediates its multiple cardiac benefits are only partly understood. Prior comprehensive analyses of the cardiac transcriptional components and microRNAs dynamically regulated by exercise suggest that the CBP/p300-interacting protein CITED4 is a downstream effector in both networks. While CITED4 has documented functional consequences in neonatal cardiomyocytes in vitro, nothing is known about its effects in the adult heart. To investigate the impact of cardiac CITED4 expression in adult animals, we generated transgenic mice with regulated, cardiomyocyte-specific CITED4 expression. Cardiac CITED4 expression in adult mice was sufficient to induce an increase in heart weight and cardiomyocyte size with normal systolic function, similar to the effects of endurance exercise training. After ischemia-reperfusion, CITED4 expression did not change initial infarct size but mediated substantial functional recovery while reducing ventricular dilation and fibrosis. Forced cardiac expression of CITED4 also induced robust activation of the mTORC1 pathway after ischemic injury. Moreover, pharmacological inhibition of mTORC1 abrogated CITED4’s effects in vitro and in vivo. Together, these data establish CITED4 as a regulator of mTOR signaling that is sufficient to induce physiologic hypertrophy at baseline and mitigate adverse ventricular remodeling after ischemic injury.
- 16 June 2016
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 1 (9)
Open AccessCITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury
The mechanisms by which exercise mediates its multiple cardiac benefits are only partly understood. Prior comprehensive analyses of the cardiac transcriptional components and microRNAs dynamically regulated by exercise suggest that the CBP/p300-interacting protein CITED4 is a downstream effector in both networks. While CITED4 has documented functional consequences in neonatal cardiomyocytes in vitro, nothing is known about its effects in the adult heart. To investigate the impact of cardiac CITED4 expression in adult animals, we generated transgenic mice with regulated, cardiomyocyte-specific CITED4 expression. Cardiac CITED4 expression in adult mice was sufficient to induce an increase in heart weight and cardiomyocyte size with normal systolic function, similar to the effects of endurance exercise training. After ischemia-reperfusion, CITED4 expression did not change initial infarct size but mediated substantial functional recovery while reducing ventricular dilation and fibrosis. Forced cardiac expression of CITED4 also induced robust activation of the mTORC1 pathway after ischemic injury. Moreover, pharmacological inhibition of mTORC1 abrogated CITED4’s effects in vitro and in vivo. Together, these data establish CITED4 as a regulator of mTOR signaling that is sufficient to induce physiologic hypertrophy at baseline and mitigate adverse ventricular remodeling after ischemic injury.